Product
Red Blood Cell Transfusion
2 clinical trials
5 indications
Indication
Sickle Cell DiseaseIndication
ThalassemiaIndication
Pediatric CancerIndication
Heart AttackIndication
AnaemiaClinical trial
Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients (RBC-IMPACT)Status: Completed, Estimated PCD: 2024-03-31